| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Oct―18 |
Outcome of COVID-19 Patients Presented with Gastrointestinal and Hepatic Manifestations |
Aye Min Soe, Kyaw Ko Ko Aung, Min Ag Shan, Pann Ei San, Khaing Kyaw Lin, Si Phyo Thu, Than Than Aye |
| 2 |
[GO] |
2022―Jul―12 |
Outcomes of COVID-19 among Patients with Chronic Liver Disease: A Danish Prospective, Population-Based Cohort Study |
Pernille Dahlin, Zainab Gassem Nagras, Mohamed Attauabi, Johan Burisch, Flemming Bendtsen, Nina Kimer, Soe Thiha Maung |
| 3 |
[GO] |
2022―Mar―13 |
Prospective Validation of Edinburgh Dysphagia Score as a Triaging Tool beyond the COVID-19 Era |
Hannah B. Walton, Dean McAvoy, Rahul Kalla, Norma McAvoy, Nicholas Church, Ian D. Penman, et al. (+5) Andrew Williams, Kenneth Trimble, Gail S. M. Masterton, John N. Plevris, Stephen D. H. Malnick |
| 4 |
[GO] |
2022―Feb―09 |
Use of Proton-Pump Inhibitor Is Not Associated with Adverse Clinical Outcomes in COVID-19 Patients: A Territory-Wide Cohort Study |
Terry Cheuk-Fung Yip, Francis Ka-Leung Chan, Grace Chung-Yan Lui, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Sunny Hei Wong, et al. (+5) Joyce Wing-Yan Mak, Siew-Chien Ng, David Shu-Cheong Hui, Grace Lai-Hung Wong, Than Than Aye |
| 5 |
[GO] |
2021―Jul―26 |
Re: Risk of extrahepatic cancer in a nationwide cohort of hepatitis C virus-infected persons treated with direct-acting antivirals: Public health impact amongst Swedish cohort in the Covid-19 pandemic era |
Saumya Pandey |
| 6 |
[GO] |
2021―Jul―02 |
Review Article: SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease |
Ralley E. Prentice, Clarissa Rentsch, Aysha H. Al-Ani, Eva Zhang, Douglas Johnson, John Halliday, et al. (+7) Robert Bryant, Jacob Begun, Mark G Ward, Peter J Lewinden, Susan J Connor, Simon Ghaly, Britt Christensen |
| 7 |
[GO] |
2021―May―02 |
Liver injury, SARS-CoV-2 infection and COVID-19: what physicians should really know? |
Anna Licata, Maria Giovanna Minissale, Marco Distefano, Giuseppe Montalto |
| 8 |
[GO] |
2021―Feb―03 |
Assessing efficacy of hepatocellular carcinoma prediction scores to prioritise hepatitis B surveillance in the COVID-19 era |
Ricky Sinharay, Andrew J. Grant, Lucy Rivett, Rebecca Blackwell, George Mells, William Gelson |
| 9 |
[GO] |
2020―Dec―10 |
Inflammatory bowel disease service redesign during the COVID-19 pandemic: Living, learning and delivering care amidst angst and uncertainty |
Jimmy K. Limdi |
| 10 |
[GO] |
2020―Nov―15 |
The effects of COVID-19 on IBD Prescribing and Service Provision in a UK tertiary centre |
Esha Sharma, Susanna Meade, Francesca D’Errico, Polychronis Pavlidis, Raphael Luber, Sebastian Zeki, et al. (+14) Katie Hill, Alexa Duff, Dearbhaile O’Hanlon, Sherill Tripoli, Anna Stanton, Andra Caracostea, Sailish Honap, Rebecca Reynolds, Simon Anderson, Shuvra Ray, Joel Mawdsley, Jeremy Sanderson, Mark A Samaan, Peter M Irving |
| 11 |
[GO] |
2020―Aug―04 |
Impact of COVID-19 pandemic on surveillance of hepatocellular carcinoma: a study in patients with chronic hepatitis C after sustained virologic response |
Hidenori Toyoda, Satoshi Yasuda, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, et al. (+8) Shusuke Kitabatake, Satoshi Yamamoto, Shohei Shiota, Manabu Furoi, Takahiro Koyabu, Daiju Furukawa, Takashi Kumada, Yoshio Sumida |
|
